Article

The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genes

2024-01-02

Abstract excerpt

<h4>Background: </h4> and aim: Skin cutaneous melanoma (SKCM) is a fatal type of skin cancer that arises from the malignant conversion of melanocytes. Different melanoma patients show various immunotherapy responses, which may involve many immunotherapy-related genes in T cells (IRTGs). This study aims to construct a risk score model that can predict the prognosis and immunotherapy response of SKCM patients. <h4>...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0be4966d-c38e-571d-ab8f-23787d2fe3dc
DOI: 10.21203/rs.3.rs-3796710/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The combination of single-cell and bulk RNA sequencing analysis decodes the melanoma tumor microenvironment and identifies novel T cell-associated signature genesDOI 10.21203/rs.3.rs-3796710/v1Read

Combining single-cell and bulk RNA sequencing to identify CAF-related signature for prognostic prediction and treatment response in patients with melanomaSemantic proximity Read

A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironmentSemantic proximity Read

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden.Semantic proximity Read

Immuno-Genomic Landscape of Cutaneous Melanoma Identifies a Prognostic and Immunotherapeutically Relevant Gene SignatureSemantic proximity Read

Integrative single-cell profiling of melanoma reveals a tumor microenvironment signature predictive of immunotherapy responseSemantic proximity Read

Prediction of immunotherapy responsiveness in melanoma through single-cell sequencing-based characterization of the tumor immune microenvironmentSemantic proximity Read

Multi-omics construction of prognostic and immunotherapy-related gene signature and small molecule drug prediction for skin cutaneous melanomaSemantic proximity Read

Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.Semantic proximity Read

Prognostic Modeling of Patients with Metastatic Melanoma Based on Tumor Immune Microenvironment CharacteristicsSemantic proximity Read

Developing a prognostic model for skin melanoma based on the persistent tumor mutation burden and determining IL17REL as a therapeutic target.Semantic proximity Read

A cross-scale multimodal framework identifies clinically actionable immunotherapy biomarkers in melanoma through bulk to single-cell and spatial transcriptomics integrationSemantic proximity Read

Identification and validation of three risk models in skin melanoma based on bioinformatics analysisSemantic proximity Read